STStevanato Group STVN · NYSE
$19.40 -1.22% (-$0.24)
- Market cap
- 4.82B €
- Enterprise value
- 5.18B €
- P/E
- 35.9x
- Forward P/E
- 32.3x
- PEG
- 2.6x
- P/S
- 3.9x
- P/FCF
- -
- EV/EBITDA
- 19.1x
- ROIC
- 6.4%
- Gross margin
- 29.2%
- Net margin
- 11.0%
- Dividend yield
- 0.32%
- Payout ratio
- 11.4%
- Net debt/EBITDA
- 1.3x
- Beta
- 0.78
- Free float
- 100.0%
About the company
Stevanato Group S.p.A. is a global company based in Italy specializing in providing comprehensive solutions in pharmaceutical and biotechnology packaging. With over 70 years of history, Stevanato Group is known for its expertise in the development and production of innovative packaging materials, including glass vials, syringes, and specialized systems for injectable drugs. The company also offers services related to drug filling and distribution, including process automation and digital solutions for tracking and securing deliveries. Stevanato Group is a leader in the development and production of primary packaging for the pharmaceutical industry and has a strong global presence. Shares of Stevanato Group S.p.A. (ticker not disclosed) may be suitable for investors seeking opportunities in pharmaceutical packaging materials and services with a focus on industry growth and innovation.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Franco Stevanato
Employees
6,010
Headquarters
Piombino Dese
Valuation
Is today's price reasonable?
- What to watch: The share price is above the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: Analysts expect revenue to grow by 12% this fiscal year.
- What to watch: Earnings per share fell by 2.6% a year over the last 3 years.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 EUR of revenue, 11 EUR is left as net profit.
- What to watch: It reports a profit, yet spends more cash than it brings in.
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number